Literature DB >> 15650638

In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection.

Daniel Azoulay1, Rony Eshkenazy, Paola Andreani, Denis Castaing, René Adam, Philippe Ichai, Salima Naili, Eric Vinet, Faouzi Saliba, Antoinette Lemoine, Marie-Christine Gillon, Henri Bismuth.   

Abstract

SUMMARY BACKGROUND DATA: We compare the results of liver resection performed under in situ hypothermic perfusion versus standard total vascular exclusion (TVE) of the liver <60 minutes and > or =60 minutes in terms of liver tolerance, liver and renal functions, postoperative morbidity, and mortality. The safe duration of TVE is still debated. Promising results have been reported following TVE associated with hypothermic perfusion of the liver with durations of up to several hours. The 2 techniques have not been compared so far.
METHODS: The study population includes 69 consecutive liver resections under TVE <60 minutes (group TVE<60', 33 patients), > or =60 minutes (group TVE> or =60', 16 patients), and in situ hypothermic perfusion (group TVEHYOPOTH, 20 patients). Liver tolerance (peaks of transaminases), liver and kidney function (peak of bilirubin, minimum prothrombin time, and peak of creatinine), morbidity, and in-hospital mortality were compared within the 3 groups.
RESULTS: The postoperative peaks of aspartate aminotransferase (IU/L) and alanine aminotransferase (IU/L) were significantly lower (P[r] < 0.05) in group TVE HYPOTH (450 +/- 298 IU/L and 390 +/- 391 IU/L) compared with the groups TVE<60' (1000 +/- 808; 853 +/- 743) and TVE> or =60' (1519 +/- 962; 1033 +/- 861). In the group TVEHYPOTH, the peaks of bilirubin (micromol/L) (84 +/- 31), creatinine (micromol/L) (75 +/- 22), and the number of complications per patient (1.2 +/- 0.9) were comparable to those of the group TVE<60' (80 +/- 111; 109 +/- 77; and 0.8 +/- 1.1 respectively) and significantly lower to those of the group TVE> or =60' (196 +/- 173; 176 +/- 176, and 2.6 +/- 1.8). In-hospital mortality rates were 1 in 33, 2 in 16, and 0 in 20 for the groups TVE<60', TVE> or =60', and TVEHYOPOTH, respectively, and were comparable. On multivariate analysis, the size of the tumor, portal vein embolization, and a planned vascular reconstruction were significantly predictive of TVE > or =60 minutes.
CONCLUSIONS: Compared with standard TVE of any duration, hypothermic perfusion of the liver is associated with a better tolerance to ischemia. In addition, compared with TVE > or =60 minutes, it is associated with better postoperative liver and renal functions and a lower morbidity. Predictive factors for TVE > or =60 minutes may help to indicate hypothermic perfusion of the liver.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650638      PMCID: PMC1356913          DOI: 10.1097/01.sla.0000152017.62778.2f

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  54 in total

1.  Partial autotransplantation of the liver in hepatocellular carcinoma complicating cirrhosis.

Authors:  K Kumada; Y Yamaoka; T Morimoto; K Tanaka; F Moriyasu; T Yamaguchi; K Mori; A Tanaka; K Ozawa
Journal:  Br J Surg       Date:  1992-06       Impact factor: 6.939

2.  Liver resection with total vascular exclusion for malignant tumours.

Authors:  N Habib; G Zografos; G Dalla Serra; L Greco; A Bean
Journal:  Br J Surg       Date:  1994-08       Impact factor: 6.939

3.  A new percutaneous technique for establishing venous bypass access in orthotopic liver transplantation.

Authors:  A C Oken; S M Frank; W T Merritt; J Fair; A Klein; J Burdick; S Thompson; C Beattie
Journal:  J Cardiothorac Vasc Anesth       Date:  1994-02       Impact factor: 2.628

4.  Reconstruction of the middle hepatic vein tributary during right anterior segmentectomy.

Authors:  T Kakazu; M Makuuchi; S Kawasaki; S Miyagawa; Y Nakazawa; T Kubota; T Takayama; T Kosuge
Journal:  Surgery       Date:  1995-02       Impact factor: 3.982

5.  Reconstruction of the hepatic vein to the prosthetic inferior vena cava in right extended hemihepatectomy with ex situ procedure.

Authors:  T Yagyu; R Shimizu; M Nishida; K Nakashima; T Uchiyama; T Suzuki
Journal:  Surgery       Date:  1994-06       Impact factor: 3.982

6.  Liver resection with normothermic ischaemia exceeding 1 h.

Authors:  L Hannoun; D Borie; E Delva; D Jones; J C Vaillant; B Nordlinger; R Parc
Journal:  Br J Surg       Date:  1993-09       Impact factor: 6.939

7.  Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  J Yamamoto; T Kosuge; T Takayama; K Shimada; S Yamasaki; H Ozaki; N Yamaguchi; S Mizuno; M Makuuchi
Journal:  Surgery       Date:  1994-03       Impact factor: 3.982

8.  Liver resection under total vascular isolation. Variations on a theme.

Authors:  S Emre; M E Schwartz; E Katz; C M Miller
Journal:  Ann Surg       Date:  1993-01       Impact factor: 12.969

9.  Extracorporeal hepatic resection for previously unresectable neoplasms.

Authors:  K Yanaga; K Kishikawa; M Shimada; S Kakizoe; H Higashi; T Nishizaki; T Matsumata; T Kanematsu; K Sugimachi
Journal:  Surgery       Date:  1993-06       Impact factor: 3.982

10.  Simplified hepatic resection with the use of prolonged vascular inflow occlusion.

Authors:  J Terblanche; J E Krige; P C Bornman
Journal:  Arch Surg       Date:  1991-03
View more
  36 in total

Review 1.  Small for size liver remnant following resection: prevention and management.

Authors:  Rony Eshkenazy; Yael Dreznik; Eylon Lahat; Barak Bar Zakai; Alex Zendel; Arie Ariche
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

Review 2.  [Vascular reconstruction in hepatic surgery].

Authors:  S Heinrich; J Baumgart; J Mittler; H Lang
Journal:  Chirurg       Date:  2016-02       Impact factor: 0.955

3.  Single-Centre Experience of Supra-Renal Vena Cava Resection and Reconstruction.

Authors:  Nikola Vladov; Radoslav Kostadinov; Vassil Mihaylov; Ivelin Takorov; Tsonka Lukanova; Maria Yakova; Tsvetan Trichkov; Evelina Odisseeva; Ventsislav Mutafchiyski
Journal:  World J Surg       Date:  2021-03-16       Impact factor: 3.352

4.  Ischemia-reperfusion injury in rat steatotic liver is dependent on NFκB P65 activation.

Authors:  Sabarinathan Ramachandran; Jane M Liaw; Jianluo Jia; Sean C Glasgow; Wei Liu; Krista Csontos; G A Upadhya; T Mohanakumar; William C Chapman
Journal:  Transpl Immunol       Date:  2012-01-21       Impact factor: 1.708

Review 5.  Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantation.

Authors:  D Gomez; S Homer-Vanniasinkam; A M Graham; K R Prasad
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

6.  Combined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experience.

Authors:  Daniel Azoulay; Paola Andreani; Umberto Maggi; Chadi Salloum; Fabiano Perdigao; Mylène Sebagh; Antoinette Lemoine; René Adam; Denis Castaing
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

Review 7.  Portal triad clamping versus other methods of vascular control in liver resection: a systematic review and meta-analysis.

Authors:  Arthur J Richardson; Jerome M Laurence; Vincent W T Lam
Journal:  HPB (Oxford)       Date:  2012-04-26       Impact factor: 3.647

Review 8.  Pharmacological interventions for ischaemia reperfusion injury in liver resection surgery performed under vascular control.

Authors:  Mahmoud Abu-Amara; Kurinchi Selvan Gurusamy; George Glantzounis; Barry Fuller; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

9.  Validation of a Nomogram to Predict the Risk of Perioperative Blood Transfusion for Liver Resection.

Authors:  Fabio Bagante; Gaya Spolverato; Andrea Ruzzenente; Ana Wilson; Faiz Gani; Simone Conci; Alexander Yahanda; Tommaso Campagnaro; Alfredo Guglielmi; Timothy M Pawlik
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

10.  Ex-situ liver surgery without veno-venous bypass.

Authors:  Ke-Ming Zhang; Xiong-Wei Hu; Jia-Hong Dong; Zhi-Xian Hong; Zhao-Hai Wang; Gao-Hua Li; Rui-Zhao Qi; Wei-Dong Duan; Shao-Geng Zhang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.